M?
Inhibits hepatic production of vitK-dependent coagulation factors and cofactors
Inhibits VitK epoxide reductase, which reactivates vitK once oxidised so coagulation factors cannot be made.
I?
prevents clot extension and recurrence in DVT or PE
prevents complications in AF/heart valve replacement
C?
risk of haemorrhage, liver disease, trauma, pregnancy,ccp450 inhibitors/inducers, antibiotics
A?
bleeding
epistaxis
retroperitoneal haemorrhage